Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients

Clinical trial NCT06297369 · UNKNOWN

Trial details

NCT number: NCT06297369
Sponsor: Ain Shams University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Cisplatin Adverse Reaction Cisplatin Nephrotoxicity Cisplatin Induced Peripheral Neuropathy Cancer Patients Cisplatin Ototoxicity

Start date: 2024-02-01
Primary completion: 2025-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.